Industry Overview - The U.S. cannabis market is projected to exceed $50 billion annually within the next decade, indicating strong long-term growth potential [1] - Federal reform discussions and state-level legalization are driving investor interest in leading multi-state operators [1] Company Profiles Trulieve Cannabis Corp. (TCNNF) - Trulieve is one of the largest U.S. cannabis operators, with over 190 dispensaries nationwide, including more than 130 in Florida, giving it a dominant market share [3][5] - The company has expanded into states like Arizona, Pennsylvania, and Georgia, maintaining fully integrated operations across its markets [5] - In the most recent quarter, Trulieve reported revenue of approximately $298 million, with gross profit margins exceeding 50% and adjusted EBITDA around $80 million [6][8] Curaleaf Holdings Inc. (CURLF) - Curaleaf is the largest U.S. cannabis company by revenue, operating about 150 dispensaries, primarily in Florida, Arizona, and Massachusetts [9][11] - The company has a diverse product portfolio and is expanding internationally, particularly in Europe, which adds to its growth potential [11] - Curaleaf generated approximately $342 million in revenue in its latest quarter, with gross margins above 45% and adjusted EBITDA near $80 million [12][13] Cresco Labs Inc. (CRLBF) - Cresco Labs focuses on wholesale distribution and operates over 60 dispensaries, primarily in Illinois, Pennsylvania, Ohio, and Massachusetts [14][16] - The company is one of the largest branded cannabis product distributors in the U.S., ensuring consistent product quality through its integrated operations [16] - In its most recent quarter, Cresco reported revenue of approximately $194 million, with gross margins over 45% and adjusted EBITDA around $45 million [17][18] Market Dynamics - The U.S. cannabis industry is characterized by opportunities and challenges, with federal reform being a key catalyst for growth [19] - Competition, pricing pressures, and regulatory complexities necessitate disciplined management and operational efficiency among cannabis operators [19] - Trulieve, Curaleaf, and Cresco have demonstrated the scale and adaptability needed to navigate the current market environment [20]

NORWOOD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2025. Management Commentary “We delivered growth and expanded operations across our business during the second quarter, continuing our progress of building a leading cannabis consumer packaged goods company,” said Jon Levine, MariMed Chief ...

Core Insights - iAnthus Capital Holdings, Inc. has opened its 22nd GrowHealthy dispensary in Palm Harbor, Florida, enhancing patient access to premium medical cannabis products [1][2] - The new dispensary aims to provide a modern retail experience focused on patient needs, featuring a variety of products including flower, vapes, and concentrates [2][3] - The grand opening aligns with iAnthus' strategy to expand its footprint in Florida's cannabis market while emphasizing high-quality genetics and whole-plant wellness [3][5] Company Overview - iAnthus is a vertically integrated cannabis company focused on building premium brands through cultivation, production, and retail operations across the United States [5] - The company leverages acquisition-driven growth and access to capital to create a long-term competitive advantage [5] - iAnthus' brand portfolio includes MPX, Anthologie, Black Label, Cheetah, Frūtful, Last Resort, Moodz, and Sunshine State [5]

Core Viewpoint - Canopy Growth has significantly underperformed in the cannabis industry, losing 99% of its value over the past five years, with shares trading under $2, making it unattractive for investment [1][11]. Financial Performance - Canopy Growth reported a net revenue of 65 million Canadian dollars for Q4 of fiscal year 2025, down 11% year-over-year, despite a 4% increase in cannabis revenue in Canada [6]. - The company remains deeply unprofitable, with a net loss per share of CA$1.43, worsening from a CA$1.03 loss per share in the previous year [7]. Market Challenges - The cannabis market is heavily regulated, leading to stiff competition and oversupply issues, particularly in Canada and the U.S., where cannabis remains illegal at the federal level [4][10]. - Canopy Growth's international operations, including its subsidiary Storz & Bickel, have not mitigated the negative impact on overall performance [2][6]. Management Outlook - Management has attempted to present a positive outlook by highlighting a 49% reduction in total debt during fiscal year 2025 and aims to achieve positive adjusted EBITDA in the "near term" [8][9]. - Despite potential long-term opportunities in the U.S. cannabis market, the vague nature of management's goals raises skepticism about the company's future profitability [8][9]. Investment Sentiment - The current lack of revenue growth and the uncertain regulatory environment in the U.S. contribute to the view that Canopy Growth is not an attractive investment option [10][11].

Dividend Stocks Overview - Dividend yield is a key metric for investors, indicating how much a company pays in annual dividends relative to its stock price [1] - The sustainability of a company's dividend yield is often assessed through its dividend payout ratio, which shows the percentage of net income distributed as dividends [1][3] - A high dividend yield may result from a declining stock price, which could indicate underlying issues [2] Altria Group (MO) - Altria Group has a dividend yield of 6.83% and an annual dividend of $4.08, with a payout ratio of 68.34% [5][6] - The company has a strong track record of 56 consecutive years of dividend increases and an annualized 3-year dividend growth of 4.35% [5][8] - Despite the decline in traditional tobacco smoking, Altria is pivoting towards alternative nicotine products, which may support future revenue and earnings growth [7] - The stock has delivered a total return of over 609% in the last 15 years, and its current P/E ratio of 9x indicates it is undervalued compared to its historical performance [6][7] United Parcel Service (UPS) - UPS has a dividend yield of 6.88% and an annual dividend of $6.56, with a high payout ratio of 95.63% [9][10] - The company has a history of maintaining dividends even during economic downturns, with a cash flow payout ratio of 66% [10] - UPS is undergoing a turnaround plan that is expected to improve margins, and its P/E ratio is around 14x, which is a discount to historical averages [11] Verizon Communications (VZ) - Verizon has a dividend yield of 6.25% and an annual dividend of $2.71, with a payout ratio of 64.52% [12][14] - The company has a 20-year track record of dividend increases, but its recent total return over 10 years is only 45.22% [13][14] - Verizon is facing challenges with subscriber losses but has received FCC approval for a deal to acquire Frontier, which may enhance its competitive position [13][14]

Core Viewpoint - Verano Holdings Corp. is expanding its retail presence in Connecticut with the opening of Zen Leaf Enfield, increasing its total dispensary count to 157 nationwide, and actively engaging in community development projects [1][2][5]. Group 1: Company Expansion - Zen Leaf Enfield will officially open on May 23, 2025, marking the seventh retail location for Verano in Connecticut [1]. - The company now operates 157 dispensaries across the United States and has 15 cultivation and processing facilities with over 1.1 million square feet of cultivation capacity [5][9]. Group 2: Community Engagement - Verano is supporting the Thompsonville Fire Department by providing funds for a year's supply of Narcan to aid in combating the opioid crisis [3][5]. - The company is also involved in local charitable initiatives, including a food donation drive for Enfield Loaves and Fishes and Enfield Food Shelf [3][5]. Group 3: Grand Opening Activities - The Grand Opening celebration will feature various activities, including a ceremonial ribbon cutting with community leaders and local partners [6][7]. - Special promotions will be available during the opening weekend, including discounts on cannabis products and complimentary food from local vendors [6][8]. Group 4: Local Economic Development - Zen Leaf Enfield is strategically located near the Enfield Square Mall, which is undergoing a $250 million redevelopment into the Enfield Marketplace, aimed at boosting local economic growth [2][5]. - The company aims to contribute to the long-term success of the Enfield community by investing in local job opportunities [2].